Navigation Links
Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors
Date:4/28/2009

of the Board of Directors, provide superior value to stockholders than the value of the estimated distributions under the Plan of Dissolution, taking into account all factors that could affect valuation, including timing and certainty of closing, credit market risks, proposed terms and other factors, the Plan of Dissolution could be abandoned in favor of such a transaction.

IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE SEC.

This press release is for informational purposes only. It is not a solicitation of a proxy. In connection with the Plan of Dissolution, the Company intends to file with the SEC a definitive proxy statement and other relevant materials. THE COMPANY'S STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE PLAN OF DISSOLUTION. Stockholders may obtain a free copy of the proxy statement and the other relevant materials (when they become available), and any other documents filed by the Company with the SEC, at the SEC's web site at www.sec.gov. In addition, the Company will mail a copy of the definitive proxy statement to stockholders of record on the record date when it becomes available. A free copy of the proxy statement, when it becomes available, and other documents filed with the SEC by the Company may also be obtained by directing a written request to: Genaera Corporation, Attn: Secretary, 5110 Campus Drive, Plymouth Meeting, PA 19462, or accessing the "Investor Relations"' section of the Company's website at www.genaera.com. Stockholders are urged to read the proxy statement and the other relevant materials when they become available before making any voting or investment decision with respect to the Plan of Dissolution.

About Genaera

'/>"/>
SOURCE Genaera Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
3. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
4. Xmark Comments on Genaera Cost-Saving Plan
5. Genaera Corporations 2008 Annual Stockholder Meeting Results
6. Genaera Receives Non-Compliance Notice From NASDAQ
7. Genaera to Present at Therapeutic Area Partnerships 2008
8. Genaera to Participate in Obesity Panel at RBC Capital Markets Healthcare Conference
9. Genaera to Present at BIO CEO & Investor Conference
10. Genaera Corporation Announces 2008 Financial Results
11. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 02, 2015 , ... Ericson is a noted speaker and educator in the ... Director of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where she ... Camps. She serves as a CDI subject matter expert for a variety of HCPro ...
(Date:9/2/2015)... ... 2015 , ... The 2015 China Overseas Investment and Entrepreneurship ... conference will be hosted at five star Beijing Kunlun Hotel and Diaoyutai State ... feature leading EB-5 industry professionals and Chinese private equity partners looking for international ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... the upper extremity surgical market, announced today that more than 600 successful patient ... in the hand. Plus, nearly 70 of these procedures have been on ...
(Date:9/2/2015)... , ... September 02, 2015 , ... On September 9, ... attend doTERRA’s annual convention, the largest single-company convention to date for the state of ... look forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the ...
(Date:9/2/2015)... ... , ... The payroll conference theme this year is "TAKING ... legislative updates, including unemployment, global payroll best practices, and the latest trends in ... the American Payroll Association, Barnett Associates, and the IRS, will keep payroll professionals ...
Breaking Medicine News(10 mins):Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:23rd Annual NJ Statewide Payroll Conference in Vernon, NJ at the Minerals Hotel on October 15-16, 2015 2
... A factor, once known as oscillin, carried by ... oscillations in free calcium necessary to bring about a ... is a strong candidate for oscillin. Eventually PLCZ1 undergoes ... to promote calcium oscillations ceases. One would reasonably think ...
... Representatives not to Concur on Senate Budget,which Includes Elimination ... May 23 Many older,Illinoisans were left out of ... includes severe cuts to several programs and,services that allow ... own choice and avoid costly and premature,institutional care. AARP ...
... 23 Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ... Bisaro, Watson,s president and chief,executive officer, will provide ... the UBS Global Specialty and Generic Pharmaceuticals Conference,on ... BST (9:30 a.m. EDT)., This presentation will ...
... the Army,s 2nd Battalion, 113th Infantry Regiment yesterday ... for their upcoming,deployment in Iraq. Instead of shooting ... procedure that allows them to have 20/20 vision ... Drs. Joseph and Jeffery Dello Russo marked ...
... In response to the,devastating 7.9 magnitude earthquake that ... public and corporations have generously supported,American Red Cross ... grateful for the outpouring of compassion,we,ve received from ... Meltzer, senior vice president, International Services for the,American ...
... condition can strike anyone , , FRIDAY, May 23 (HealthDay News) ... a four-time NBA All-Star, and head coach of the Philadelphia ... gout. , "I had no idea what gout was," Cheeks ... 46 -- with the often-debilitating arthritic condition. "Never heard of ...
Cached Medicine News:Health News:June 2008 highlights 2Health News:Soldiers Receive Free Memorial Day Lasik Surgery Before Going to Iraq 2Health News:America Generously Responds to China Earthquake 2Health News:Basketball Star Details His Struggle With Gout 2Health News:Basketball Star Details His Struggle With Gout 3
(Date:9/2/2015)... 2, 2015 Amgen (NASDAQ: AMGN ... Authorization Application (MAA) to the European Medicines Agency ... AMG 416) for the treatment of secondary hyperparathyroidism ... (CKD) on hemodialysis therapy. If approved, etelcalcetide will ... administered intravenously. Etelcalcetide is a novel ...
(Date:9/2/2015)... Gulf Coast Tattoo Removal is the first and only laser ... in Southern Mississippi . Gulf Coast Tattoo Removal ... back control of their skin. The clinic is located in ... Biloxi , Gulfport , and the ... prevalent as it is, I was surprised by the lack of ...
(Date:9/2/2015)... 2, 2015 Research and Markets ( ... "An Introduction to Medical Device Software: Regulations ... conference to their offering. ... the regulations and requirements that apply to Medical ... using real life examples and state-of- the-art practices ...
Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
Cer-Met series II system....
The Ceracup has a standard profile plastic component with a ceramic insert and the benefit of alumina-alumina contact....
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Medicine Products: